Related references
Note: Only part of the references are listed.EXTENDED REPORT Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
Jean-Yves Reginster et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1β in the synovium
Jean-Pierre Pelletier et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Re: Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial. Cooper C, Reginster JY, Chapurlat R, et al. Curr Med Res Opin 2012;28:231-9.
Hamid Namazi
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial
Cyrus Cooper et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts
Steeve Kwan Tat et al.
BONE (2011)
Osteoarthritis: an update with relevance for clinical practice
Johannes W. J. Bijlsma et al.
LANCET (2011)
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT
Allen D. Sawitzke et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Clinically Important Improvement in Function Is Common in People with or at High Risk of Knee OA: The MOST Study
Daniel K. White et al.
JOURNAL OF RHEUMATOLOGY (2010)
The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Effects of strontium ranelate on spinal osteoarthritis progression
O. Bruyere et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis
N Bellamy et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement
F Tubach et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.
T Pham et al.
OSTEOARTHRITIS AND CARTILAGE (2004)
A taxonomy for responsiveness
DE Beaton et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
Share Paper
